Back

Salarius Pharmaceuticals to Present During Virtual LD 500 Conference

Read More

Back

Salarius Pharmaceuticals Reports Business Highlights and Second Quarter 2020 Financial Results

Read More

Back

Salarius Pharmaceuticals to Report Second Quarter 2020 Financial Results

Read More

Back

Salarius Announces Issuance of New Patent for Seclidemstat by European Patent Office

Read More

Back

Salarius Announces Closing of $6.2 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option

Read More